Trial · NCT00623623
Registered outcomes25
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 25
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Patients With All-cause Mortality, Cardiogenic Shock, Congestive Heart Failure and Recurrent Myocardial Infarction Within 30 Days for FAS. | 30 days | The number of observed patients with all-cause mortality, cardiogenic shock, congestive heart failure (CHF) and recurrent myocardial infarction within 30 days was reported for full analysis set (FAS). |
| Secondary | Number of Patients With All Cause Mortality | 30 days | This is a key secondary endpoint. The number of observed patients with all cause mortality within 30 days was reported. |
| Secondary | Number of Patients With Cardiac Mortality | 30 days | This is a key secondary endpoint. The number of observed patients with cardiac mortality within 30 days was reported. |
| Secondary | Number of Patients With Cardiogenic Shock | 30 days | This is a key secondary endpoint. The number of observed patients with cardiogenic shock within 30 days was reported. |
| Secondary | Number of Patients With Congestive Heart Failure (CHF) | 30 days | This is a key secondary endpoint. The number of observed patients with congestive heart failure (CHF) within 30 days was reported. |
| Secondary | Number of Patients With Recurrent Myocardial Infarction (Reinfarction) | 30 days | This is a key secondary endpoint. The number of observed patients with recurrent myocardial infarction (reinfarction) within 30 days was reported |
| Secondary | Number of Patients With Rehospitalisation for Cardiac Reasons | 30 days | This is a key secondary endpoint. The number of observed patients with rehospitalisation for cardiac reasons within 30 days was reported |
| Secondary | Number of Patients With Rehospitalisation for Non-cardiac Reasons | 30 days | This is a key secondary endpoint. The number of observed patients with rehospitalisation for non-cardiac reasons within 30 days was reported |
| Secondary | Number of Patients With Serious Repeat Target Vessel Revascularization | 30 days | This is a key secondary endpoint. The number of observed patients with serious repeat target vessel revascularization within 30 days was reported |
| Secondary | Number of Patients With All Cause Death and Shock | 30 days | This is a key secondary endpoint. The number of observed patients with all cause death and shock within 30 days was reported |
| Secondary | Number of Patients With All Cause Death and Shock and CHF | 30 days | This is a key secondary endpoint. The number of observed patients with all cause death and shock and CHF within 30 days was reported. |
| Secondary | Number of Patients With All Cause Death and Shock and Reinfarction | 30 days | This is a key secondary endpoint. The number of observed patients with all cause death and shock and reinfarction within 30 days was reported |
| Secondary | Number of Patients With Total Fatal Stroke | 30 days | This is a key secondary endpoint. The number of observed patients with total fatal stroke within 30 days was reported |
| Secondary | Number of Patients With Total Disabling Stroke | 30 days | This is a key secondary endpoint. The number of observed patients with total disabling stroke within 30 days was reported |
| Secondary | Number of Patients With Total Non-disabling Stroke | 30 days | This is a key secondary endpoint. The number of observed patients with total non-disabling stroke within 30 days was reported |
| Secondary | Number of Patients With Intracranial Haemorrhage | 30 days | This is a key secondary endpoint. The number of observed patients with intracranial haemorrhage within 30 days was reported |
| Secondary | Number of Patients With Ischaemic Stroke | 30 days | This is a key secondary endpoint. The number of observed patients with ischaemic stroke within 30 days was reported |
| Secondary | Number of Patients With Total Stroke (All Types) | 30 days | This is a key secondary endpoint. The number of observed patients with total stroke (all types) within 30 days was reported |
| Secondary | Number of Patients With Major Non-intracranial Bleeds Including Blood Transfusions | 30 days | This is a key secondary endpoint. The number of observed patients with major non-intracranial bleeds including blood transfusions within 30 days was reported |
| Secondary | Number of Patients With Minor Non-intracranial Bleeds | 30 days | This is a key secondary endpoint. The number of observed patients with minor non-intracranial bleeds within 30 days was reported |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00623623/registered